Conference Detail Page

Neurology: Comparative effect of statins on the risk of incident Alzheimer disease

CME : 0.75
Start Date :  Jan 16 - 2018 End Date :  Jan 16 - 2021

Organized by :   American Academy of Neurology (AAN)

Specialities :   Neurology

Conference Summary

Neurology: Comparative effect of statins on the risk of incident Alzheimer disease is organized by American Academy of Neurology (AAN).

Released: 1/16/2018
Expires: 1/16/2021

Accreditation:
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
Upon completion of the article by Sinyavskaya et al, the participant should be able to:
• Describe differences in the risk of developing Alzheimer disease (AD) among patients taking fungus-based vs synthetic statin medications in this study
• Identify specific statin formulations that were associated with a higher risk of AD in this study
• Discuss differences in AD risk seen across different statin potency and different statin lipophilicity seen in this study.

Credit Info

  • CME : 0.75
Author (s)
2 Speakers
Target Audience

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

Peers Info
Number of Health Care Professionals Registered: 0 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat